Lupin Gets U.S. FDA Approval for Tramadol Painkiller Pill

Lupin Ltd. (LPC), the world’s biggest maker of anti-tuberculosis medicines, received approval from the U.S. Food and Drug Administration for its tramadol pill, the generic version of Johnson & Johnson (JNJ)’s Ultram painkiller, according to a statement on the regulator’s website.

To contact the reporter on this story: Adi Narayan in Mumbai at anarayan8@bloomberg.net

To contact the editor responsible for this story: Niveditha Ravi at nravi2@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.